C. Moriano

Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

Monica Calderón-Goercke, J. Loricera, Vicente Aldasoro et al. · Seminars in Arthritis and Rheumatism · 2019 · 105 citations · Full text

Rheumatology, Autoimmune Disease, Vasculitis +6

Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice.

Monica Calderón-Goercke, Santos Castañeda, Vicente Aldasoro et al. · PubMed · 2020 · 34 citations

Tocilizumab in Behçet's disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes

Belén Atienza‐Mateo, E. Beltrán, Marisa Hernández‐Garfella et al. · Clinical and Experimental Rheumatology · 2021 · 28 citations · Full text

The presence of both HLA-DRB1[*]04:01 and HLA-B[*]15:01 increases the susceptibility to cranial and extracranial giant cell arteritis

D. Prieto-Peña, Sara Remuzgo‐Martínez, J. Gonzalo Ocejo‐Vinyals et al. · Clinical and Experimental Rheumatology · 2021 · 26 citations · Full text

Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients

Monica Calderón-Goercke, Santos Castañeda, Vicente Aldasoro et al. · Seminars in Arthritis and Rheumatism · 2021 · 25 citations

Autoimmune Disease, Vasculitis, Monotherapy Versus +6